Bridged N-cyclic sulfonamido inhibitors of gamma secretase
Details for Australian Patent Application No. 2006279312 (hide)
International Classifications
Event Publications
3 July 2008 Section 223 Application Allowed
Elan Pharmaceuticals, Inc. The time in which to enter the National Phase has been extended to 19 Apr 2008. Address for service in Australia - Freehills Patent & Trade Mark Attorneys Level 43 101 Collins Street Melbourne VIC 3000
17 July 2008 PCT application entered the National Phase
PCT publication WO2007/022502 Priority application(s): WO2007/022502
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser